Journal of Traditional Chinese Medicine ›› 2017, Vol. 37 ›› Issue (05): 621-628.

Previous Articles     Next Articles

Jinye Baidu granule for wind-warmth lung-heat disease(heat in the lung-wei): protocol for a randomized, double-blind, parallel, controlled trial

Jiang Junjie, Zhang Yin, Xie Yanming, Li Yuan, Sun Shuailing, Zhang Yili, Wang Shuo, Zhu Yong, Qi Wensheng   

  1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences;Emergency Department, Guanganmen Hospital Affiliated to China Academy of Chinese Medical Sciences;Department of Pneumology, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University;Intensive Care Unit, Guanganmen Hospital Affiliated to China Academy of Chinese Medical Sciences;
  • Accepted:2017-10-15 Online:2017-10-15 Published:2022-04-04
  • Supported by:
    Supported by the Ninth Scientific Research Foundation of Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences(No.Z0406), the Research Project of World Federation of Chinese Medicine Societies(SCEPCM12E001), the Special Research Project of Traditional Chinese Medicines by the State Administration of Traditional Chinese Medicine(No.201507003-8)

Abstract: OBJECTIVE: To observe the curative effect of Jinye Baidu granule in the treatment of fever and swollen and sore throat caused by wind-warmth lung-heat disease(heat in the lung-wei) to further identify the indications.METHODS: This randomized, double-blind, parallel, controlled trial will include patients with acute upper respiratory infection and wind-warmth lung-heat disease(heat in the lung-wei). Patientswith serious bacterial infection(white blood cell count > 12 × 10~9, neutrophils > 80%) will be excluded. Patients will be divided into three categories(blocks) according to their condition: fever only, a swollen and sore throat, and combined fever plus a swollen and sore throat. Patients within each of the three blocks will be further divided into a treatment group and a control group via stratified blocked randomization. The treatment group will be treated with Jinye Baidu granule, and the control group will be treated with Fufang Shuanghua granule. The primary outcome measure will be body temperature recovery time for patients with fever, throat symptom score for patients with a swollen and sore throat, and body temperature recovery time and throat symptom score for patients with combined fever plus a swollen and sore throat. Routine blood testing, urine testing, liver function, kidney function and ECG data of all patients will be collected as safety indices before and after enrollment, and adverse events will be recorded during the whole trial course.CONCLUSION: This study protocol will include stratified block analysis according to patients' symptoms, and identify the accurate clinical indications of Jinye Baidu granule. It will also enable safety evaluation from laboratory indices and adverse events, which will provide reliable evidence for clinical treatment.

Key words: Syndrome of wind heat invading lung and stomach, Respiratory tract infections, Randomized controlled trial, Clinical protocols, Jinye Baidu granule

Cite this article

Jiang Junjie, Zhang Yin, Xie Yanming, Li Yuan, Sun Shuailing, Zhang Yili, Wang Shuo, Zhu Yong, Qi Wensheng. Jinye Baidu granule for wind-warmth lung-heat disease(heat in the lung-wei): protocol for a randomized, double-blind, parallel, controlled trial[J]. Journal of Traditional Chinese Medicine, 2017, 37(05): 621-628.